Lively capital : biotechnologies, ethics, and governance in global markets

Lively Capital is an urgent and important collection of essays addressing the reconfigured relations between the life sciences and the market.

Exploring the ground where social and cultural anthropology intersect with science and technology studies, prominent scholars investigate the relationship of biotechnology to ethics, governance, and markets, as well as the new legal, social, cultural, and institutional mechanisms emerging to regulate biotechnology.

The contributors examine genomics, pharmaceutical marketing, intellectual property, environmental science, clinical trials, patient advocacy, and other such matters as they are playing out in North and South America, Europe, Africa, and Asia.

Lively Capital is not only about the commercialization of the life sciences, but their institutional histories, epistemic formations, and systems of valuation.

It is also about the lively affects-the emotions and desires-involved when technologies and research impinge on experiences of embodiment, kinship, identity, disability, citizenship, accumulation, and dispossession.

At stake in the commodification of the life sciences are opportunities to intervene in and adjudicate matters of health, life, and death.Contributors.

Timothy Choy, Joseph Dumit, Michael M. J. Fischer, Kim Fortun, Mike Fortun, Donna Haraway, Sheila Jasanoff, Wen-Hua Kuo, Andrew Lakoff, Kristin Peterson, Chloe Silverman, Elta Smith, Kaushik Sunder Rajan, Travis J.

Tanner